Foundation Fighting Blindness Retinal Degeneration Fund, Director at Opus Genetics, Inc. (IRD), sold 1,700,000 shares at $4.35 ($7.4M) on 2026-05-18, disclosed to the SEC on 2026-05-20.
Open-market sale of $7.4M IRD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.